首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Efficacy and Tolerability of Fluvastatin and Simvastatin in Hypercholesterolaemic Patients
被引:0
|
作者
:
J. A. Tobert
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
J. A. Tobert
A. V. Katdare
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
A. V. Katdare
K.-L. Schulte
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
K.-L. Schulte
S. Beil
论文数:
0
引用数:
0
h-index:
0
机构:
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
S. Beil
机构
:
[1]
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
[2]
Merck Research Laboratories,Departments of Clinical Research and Pharmaceutical Research and Development
[3]
Ev. Krankenhaus Königin Elizabeth Herzberge,undefined
[4]
Städt. Krankenhause,undefined
来源
:
Clinical Drug Investigation
|
1997年
/ 13卷
/ 1期
关键词
:
D O I
:
10.2165/00044011-199713010-00007
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:56 / 57
页数:1
相关论文
共 50 条
[1]
Efficacy and tolerability of fluvastatin and simvastatin in hypercholesterolaemic patients. Reply
Schulte, KL
论文数:
0
引用数:
0
h-index:
0
机构:
STADT KRANKENHAUS, MUNICH, GERMANY
STADT KRANKENHAUS, MUNICH, GERMANY
Schulte, KL
Beil, S
论文数:
0
引用数:
0
h-index:
0
机构:
STADT KRANKENHAUS, MUNICH, GERMANY
STADT KRANKENHAUS, MUNICH, GERMANY
Beil, S
CLINICAL DRUG INVESTIGATION,
1997,
13
(01)
: 56
-
57
[2]
Efficacy and tolerability of fluvastatin and simvastatin in hypercholesterolaemic patients - A double-blind, randomised, parallel-group comparison
Schulte, KL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV HOSP CHARITE, DEPT INTERNAL MED, BERLIN, GERMANY
Schulte, KL
Beil, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV HOSP CHARITE, DEPT INTERNAL MED, BERLIN, GERMANY
Beil, S
CLINICAL DRUG INVESTIGATION,
1996,
12
(03)
: 119
-
126
[3]
Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women
Fernández, JC
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Fernández, JC
Más, R
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Más, R
Cataño, G
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Cataño, G
Menéndez, R
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Menéndez, R
Amor, AM
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Amor, AM
González, RM
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
González, RM
Alvarez, E
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Ctr Sci Res, Ctr Nat Prod, Havana 6880, Cuba
Alvarez, E
CLINICAL DRUG INVESTIGATION,
2001,
21
(02)
: 103
-
113
[4]
Comparison of the Efficacy, Safety and Tolerability of Policosanol versus Fluvastatin in Elderly Hypercholesterolaemic Women
J. C. Fernández
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
J. C. Fernández
R. Más
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
R. Más
G. Castaño
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
G. Castaño
R. Menéndez
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
R. Menéndez
A. M. Amor
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
A. M. Amor
R. M. González
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
R. M. González
E. Alvarez
论文数:
0
引用数:
0
h-index:
0
机构:
National Center for Scientific Research,Center of Natural Products
E. Alvarez
Clinical Drug Investigation,
2001,
21
: 103
-
113
[5]
DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
OSE, L
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
OSE, L
SCOTT, R
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SCOTT, R
BRUSCO, O
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BRUSCO, O
UGARTE, AC
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
UGARTE, AC
DESCAMPS, O
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
DESCAMPS, O
HELLER, F
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
HELLER, F
PAQUOT, N
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
PAQUOT, N
SCHEEN, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SCHEEN, A
BERTOLAMI, MC
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BERTOLAMI, MC
FORTI, N
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
FORTI, N
RICHTER, W
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
RICHTER, W
SELMAIER, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SELMAIER, A
ZIEGLASCH, HJ
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
ZIEGLASCH, HJ
KLOER, H
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
KLOER, H
BADE, R
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BADE, R
WANNER, C
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
WANNER, C
KOESTER, W
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
KOESTER, W
KRAEMERGUTH, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
KRAEMERGUTH, A
BILIANOU, H
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BILIANOU, H
LEFKOS, N
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
LEFKOS, N
EFTHIMIADIS, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
EFTHIMIADIS, A
KASTELEIN, J
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
KASTELEIN, J
VANDAM, M
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
VANDAM, M
VANDEWIEL, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
VANDEWIEL, A
LINTOTT, C
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
LINTOTT, C
SUNDT, E
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SUNDT, E
ISTAD, H
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
ISTAD, H
LOENNECHEN, CW
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
LOENNECHEN, CW
UTNE, E
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
UTNE, E
HOLE, T
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
HOLE, T
SKARE, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SKARE, S
URHEIM, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
URHEIM, S
CAMPODINCO, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
CAMPODINCO, S
MORALES, R
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
MORALES, R
IZA, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
IZA, A
ALVAREZ, L
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
ALVAREZ, L
SY, R
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SY, R
YEBES, R
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
YEBES, R
LEE, CY
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
LEE, CY
TAN, A
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
TAN, A
QUEK, S
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
QUEK, S
VERMAK, WJH
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
VERMAK, WJH
VORSTER, HH
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
VORSTER, HH
RAAL, FJ
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
RAAL, FJ
KELLER, U
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
KELLER, U
NOSEDA, G
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
NOSEDA, G
BONETTI, T
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BONETTI, T
CRAWFORD, GM
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
CRAWFORD, GM
BLOOMFIELD, P
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
BLOOMFIELD, P
SUTHERLAND, K
论文数:
0
引用数:
0
h-index:
0
机构:
CHRISTCHURCH HOSP, LIPID & DIABET RES GRP, CHRISTCHURCH, NEW ZEALAND
SUTHERLAND, K
CLINICAL DRUG INVESTIGATION,
1995,
10
(03)
: 127
-
138
[6]
Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia (vol 10, pg 127, 1995)
Ose, L
论文数:
0
引用数:
0
h-index:
0
Ose, L
Scott, R
论文数:
0
引用数:
0
h-index:
0
Scott, R
CLINICAL DRUG INVESTIGATION,
1995,
10
(06)
: 343
-
343
[7]
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients - A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin
Koren, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Koren, MJ
Smith, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Smith, DG
Hunninghake, DB
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Hunninghake, DB
Davidson, MH
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Davidson, MH
McKenney, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
McKenney, JM
Weiss, SR
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Weiss, SR
Schrott, HG
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Schrott, HG
Henley, RW
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Henley, RW
Tresh, P
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Tresh, P
McLain, RW
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
McLain, RW
Bakker-Arkema, RG
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Bakker-Arkema, RG
Black, DM
论文数:
0
引用数:
0
h-index:
0
机构:
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Jacksonville Ctr Clin Res, Jacksonville, FL USA
Black, DM
PHARMACOECONOMICS,
1998,
14
(01)
: 59
-
70
[8]
FLUVASTATIN EFFICACY AND TOLERABILITY IN COMPARISON AND IN COMBINATION WITH CHOLESTYRAMINE
HAGEN, E
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
HAGEN, E
ISTAD, H
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
ISTAD, H
OSE, L
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
OSE, L
BODD, E
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
BODD, E
ERIKSEN, HM
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
ERIKSEN, HM
SELVIG, V
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
SELVIG, V
BARD, JM
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
BARD, JM
FRUCHART, JC
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
FRUCHART, JC
BORGE, M
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
BORGE, M
WOLF, MC
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
WOLF, MC
PFISTER, P
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HOSP NORWAY, DEPT MED A, LIPID CLIN, N-0027 OSLO, NORWAY
PFISTER, P
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1994,
46
(05)
: 445
-
449
[9]
Efficacy of atorvastatin in patients with severe familiar hypercholesterolemia treated with pravastatin, fluvastatin and simvastatin
Fornengo, P
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Turin, Inst Internal Med, Turin, Italy
Univ Turin, Inst Internal Med, Turin, Italy
Fornengo, P
D'Affuso, S
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Turin, Inst Internal Med, Turin, Italy
Univ Turin, Inst Internal Med, Turin, Italy
D'Affuso, S
Bruno, A
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Turin, Inst Internal Med, Turin, Italy
Univ Turin, Inst Internal Med, Turin, Italy
Bruno, A
Pagano, G
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Turin, Inst Internal Med, Turin, Italy
Univ Turin, Inst Internal Med, Turin, Italy
Pagano, G
ATHEROSCLEROSIS,
1999,
144
: 190
-
190
[10]
EFFICACY AND TOLERABILITY OF GEMFIBROZIL IN HYPERCHOLESTEROLEMIC PATIENTS PREVIOUSLY TREATED WITH SIMVASTATIN
VERGANI, C
论文数:
0
引用数:
0
h-index:
0
VERGANI, C
STEFANONI, P
论文数:
0
引用数:
0
h-index:
0
STEFANONI, P
ADVANCES IN THERAPY,
1993,
10
(04)
: 189
-
196
←
1
2
3
4
5
→